FHLC
Fidelity MSCI Health Care Index ETF · PSE
- Category Equity
- Expense Ratio 0.08%
- Listing Date Oct 24, 2013
- Volume 88,703.0
- Market Cap (AUM) $3,099.6M
Performance
+1.91%
1W
+5.4%
1M
+0.49%
3M
+15.28%
6M
+6.85%
YTD
+12.03%
1Y
Top Holdings
Technical Analysis of FHLC 2024-05-10
Overview:
In analyzing the technical indicators for FHLC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
- 2017-05-31 21:09
Eli Lilly & Co.s Revenues in 1Q17(Marketrealist)
- 2017-05-30 21:08
How Johnson & Johnsons Consumer Segment Performed in 1Q17(Marketrealist)
- 2017-05-22 20:14
A Close Look at Merck & Co.s Valuation after 1Q17 Earnings(Marketrealist)
- 2017-05-07 19:37
Pfizer: Understanding Growth Drivers in 1Q17(Marketrealist)
- 2017-05-02 19:35
Is Eli Lilly & Co.s Valuation Higher Than Its Peers?(Marketrealist)
- 2017-04-30 22:29
What Do Analysts Expect from Mercks 1Q17 Earnings?(Marketrealist)
- 2017-04-23 22:36
Analyst Ratings and Recommendations for Eli Lilly(Marketrealist)
- 2017-04-23 22:06
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?(Yahoo Finance)
- 2017-04-20 03:35
Johnson & Johnsons 1Q17 Earnings: Changes in Its Growth Rate(Marketrealist)
- 2017-04-18 22:55
Lackluster J&J Q1 Pushes Healthcare ETFs Down(Yahoo Finance)
- 2017-04-06 23:57
Analyzing the Performance of Eli Lilly Stock in 1Q17(Marketrealist)
- 2017-03-16 21:06
How BMYs Virology Segment Performed in 2016(Marketrealist)
- 2017-03-16 01:09
A Cost-Efficient Avenue to Health Care Exposure(Investopedia)
- 2017-03-12 21:07
Johnson & Johnsons Revenue Trends(Marketrealist)
- 2017-03-09 19:00
- 2017-03-09 01:56
Rising Rates Not Biggest Driver For Financials(Yahoo Finance)
- 2017-03-06 21:47
- 2017-02-27 21:35
Pfizers Recent Corporate and Pipeline Developments(Marketrealist)
- 2017-02-26 18:35
Merck & Co.s Valuation after Its 4Q16 Earnings(Marketrealist)
- 2017-02-23 20:06
Merck & Co.s Profit Margins for 4Q16(Marketrealist)
- 2017-01-30 19:45
Quality and Healthcare: 2 ETFs to Watch on Outsized Volume(Yahoo Finance)
- 2017-01-26 00:35
Changes in Johnson & Johnsons Growth Rate in 4Q16(Marketrealist)
- 2017-01-24 21:20
What Can Investors Expect from Eli Lillys 4Q16 Earnings?(Marketrealist)
- 2017-01-23 18:31
- 2017-01-22 22:01
Can Q4 Earnings Revitalize Healthcare ETFs?(Yahoo Finance)
- 2017-01-22 18:36
What to Expect from JNJs Consumer Healthcare Segment(Marketrealist)
- 2017-01-17 20:55
ETFs in Focus on Robust Q4 UnitedHealth Earnings(Yahoo Finance)
- 2016-12-11 19:05
Johnson & Johnsons Pharmaceuticals Segment in 3Q16(Marketrealist)
- 2016-12-01 21:04
Mercks Januvia and Janumet: An Investors Perspective(Marketrealist)
- 2016-11-29 21:04
Understanding Pfizers Growth Contributors(Marketrealist)
- 2016-11-29 02:04
Allergans US Specialized Therapeutics Segment in 3Q16(Marketrealist)
- 2016-11-22 23:39
5 Top-Ranked Sector ETFs Thankful to Trump(Yahoo Finance)
- 2016-11-06 19:07
Pfizers 3Q16 Earnings: An Overview(Marketrealist)
- 2016-11-01 22:06
Could Allergans Revenues Show Growth in 3Q16?(Marketrealist)
- 2016-11-01 20:04
Mercks 3Q16 Valuation Cheat Sheet(Marketrealist)
- 2016-10-23 22:28
Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?(Yahoo Finance)
- 2016-10-23 20:05
How Mercks Blockbuster Drugs Are Impacting Its Revenue(Marketrealist)
- 2016-10-23 20:04
A Look at Johnson & Johnsons Consumer Segment in 3Q16(Marketrealist)
- 2016-10-20 20:06
Johnson & Johnsons Growth Rate: How Has It Fluctuated?(Marketrealist)
- 2016-10-18 22:01
Buy UnitedHealth ETFs on Upbeat Q3 Earnings(Yahoo Finance)